These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20346040)

  • 1. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
    Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
    Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrichosis of the eyelashes caused by bimatoprost.
    Tosti A; Pazzaglia M; Voudouris S; Tosti G
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
    Herane MI; Urbina F
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
    [No Abstract]   [Full Text] [Related]  

  • 4. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
    Hart J; Shafranov G
    Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iris heterochromia and unilateral eyelash hypertrichosis.
    Rao RC; Ballard TN; Chen TC
    JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
    Ochoa BE; Sah D; Wang G; Stamper R; Price VH
    J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 9. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 May; 36(5):650-1. PubMed ID: 20384740
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
    Yoelin S; Walt JG; Earl M
    Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
    Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
    Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
    Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
    J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
    Choi YM; Diehl J; Levins PC
    J Am Acad Dermatol; 2015 Apr; 72(4):712-6. PubMed ID: 25601618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin.
    Woodward DF; Tang ES; Attar M; Wang JW
    Exp Dermatol; 2013 Feb; 22(2):145-8. PubMed ID: 23278986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical prostaglandin F(2alpha) analog induced poliosis.
    Chen CS; Wells J; Craig JE
    Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
    Aydin S; Işikligil I; Tekşen YA; Kir E
    Cutan Ocul Toxicol; 2010 Sep; 29(3):212-6. PubMed ID: 20670089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
    Wester ST; Lee WW; Shi W
    Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lusher lashes, but at real risk.
    Consum Rep; 2010 Feb; 75(2):14. PubMed ID: 20361412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.